Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MRR

Global Exosome Research Markets 2022-2026 - Opportunities in Untapped Emerging Markets, Growing Interest in Exosome-based Therapeutics, & High Demand for Personalized Medicine


DUBLIN, May 23, 2022 /PRNewswire/ -- The "Global Exosome Research Market by Product and Services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell, Dendritic Cell-derived), End-user, and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

The global exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures.

By product & service, the kits & reagents segment accounted for the largest share of the exosome research market

Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other kits & reagents.

Circulating exosomal microRNAs (miRNAs) have emerged as valuable biomarker candidates, making it imperative to characterize these exosomes carefully. This has propelled the use of these entities in exosome research to develop easy-to-use kits and reagents. Additionally, isolation and purification are critical steps in exosome research protocols, contributing to their large-scale adoption in the market.

Asia Pacific: The fastest-growing region in the exosome research market

The Asia Pacific exosome research market is registered to grow at the fastest pace during the forecast period. The rising disposable income, infrastructural developments, and penetration of cutting-edge diagnostic technologies in Asian countries such as India and China offer significant growth opportunities for manufacturers and distributors of exosomes.

North America: The North America region accounted for the largest share of the exosome research market

North America accounted for the largest share of the exosome research market. The US is the key revenue contributor to the North American exosome research market. The high prevalence of cancer coupled with the increasing demand for early and effective disease diagnosis and treatment is the key factor driving market growth in the US.

Competitive Landscape

Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX PharmaGen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global exosome research market.

Premium Insights

Market Dynamics

Drivers

Restraints

Opportunities

Challenge

Impact of COVID-19 Outbreak on Exosome Research Market

Ecosystem and Value Chain Analysis

Regulatory Analysis

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/16glrr

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 21:00
QA Mentor has established a new strategic Staffing and Recruitment division from a...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of an aggregate of...

at 19:30
Bodybuilding.com, the world's largest online fitness store, has struck a deal to partner with Retail Ecommerce Ventures (REV), a global leader in ecommerce with a rapidly growing roster of well-known brands.      ...

at 19:24
Entertainment tech startup Virtuosica, Inc. has launched the beta version of its first product, the Virtuosica virtual concert platform....

at 19:00
GreenPower Motor Company Inc.  ("GreenPower"), a leading manufacturer and distributor of a diverse line of electric powered vehicles serving the cargo and delivery, shuttle, transit, and school sectors plans to host a webcast for all shareholders...

at 18:13
Atento S.A. , one of the largest providers worldwide and the leading company in customer relationship services and business process outsourcing (CRM / BPO) in Latin America, announces its Annual Shareholders Meeting was held in Luxembourg in June...



News published on 23 may 2022 at 06:15 and distributed by: